Thomas Willmes

The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2).

Michael Wiese, Katja Stefan, M. Wiese, 2016, European journal of medicinal chemistry.